サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1442914

神経内視鏡 - 世界市場の考察、競合情勢、市場予測（2030年）

Neuroendoscopy - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
神経内視鏡 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経内視鏡の市場規模は、2024年～2030年の予測期間にCAGRで4.91％の大幅な成長が見込まれています。神経内視鏡の需要は主に、脳腫瘍などの神経疾患の有病率の上昇によって後押しされています。さらに、低侵襲手術に対する需要の高まりや神経内視鏡手術に関連するさまざまな利点は、2024年～2030年の予測期間における市場成長に寄与している主な要因です。

神経内視鏡の市場力学

American Society of Clinical Oncology（ASCO）（2023）のデータによると、2020年に原発性脳腫瘍または脊髄腫瘍と診断された人は世界で約30万8,102人と推定されました。このうち脳腫瘍は、原発性中枢神経系（CNS）腫瘍全体の85％～90％を占めています。したがって、脳腫瘍のような神経疾患の有病率の上昇は、そのような神経疾患の治療と管理の必要性を生み出し、神経内視鏡市場のプラス成長をもたらします。

神経内視鏡市場のもう1つの促進要因は、低侵襲手術に対するニーズの高まりと神経内視鏡手術に関連するさまざまな利点です。神経内視鏡の低侵襲性は、しばしば手術中の出血を少なくし、輸血の必要性を減らし、全体的な手術リスクを低下させます。さらに、神経内視鏡により高解像度のイメージングが可能となるため、外科医は標的部位を正確にナビゲートし治療することができます。さらに、切開創が小さいため、手術中に体内組織が外部の汚染物質にさらされることが少なくなり、感染のリスクが軽減されます。このように、神経内視鏡手術に関連するさまざまな利点と低侵襲手術に対する需要の高まりは、予測期間の神経内視鏡市場の成長を後押しすることにつながる主な要因です。

しかし、神経内視鏡の手術や機器に関連する高いコストや、熟練した神経科医と内視鏡医の不足は、神経内視鏡市場の成長を制限する可能性のある主な抑制要因です。

神経内視鏡市場のセグメント分析

神経内視鏡市場の製品セグメントでは、軟性神経内視鏡カテゴリが2023年の神経内視鏡市場で大きな収益シェアを獲得すると推定されます。これは、軟性神経内視鏡が提供するさまざまな利点によるものと考えられます。軟性神経内視鏡は、脳内の湾曲した複雑な経路をナビゲートする能力を提供する柔軟な設計を持った特殊な医療機器であり、複雑な構造へのアクセスを強化します。さらに、軟性神経内視鏡が提供する柔軟性により低侵襲外科手術が可能になり、大きな切開の必要性が減るため、組織の損傷が少なくなり、痛みが軽減され、回復時間が短縮されます。さらに、これらの内視鏡の柔軟性と操作性により、外科医は脳、脳室、脊髄の複雑な領域に到達することができます。

したがって、上記の要因から軟性神経内視鏡カテゴリが大きな成長を記録すると予測され、それによって予測期間に神経内視鏡市場全体の成長が促進されます。

北米が神経内視鏡市場全体を独占する見込み

全地域の中で、北米が2023年の神経内視鏡市場でもっとも高いシェアを占めると予測されています。これは、脳腫瘍などのさまざまな神経疾患の患者が多いためです。さらに、発達した精巧な医療インフラのプレゼンスや、技術の進歩、製品の開発や発売において非常に強力な市場は、北米の神経内視鏡市場の成長促進要因です。

American Society of Cancer（2023）が提供したデータによると、米国では2023年に約2万4,810例の脳腫瘍と脊髄腫瘍が診断されたと推定されています。さらに、American Society of Clinical Oncology（ASCO）（2023）のデータでは、2023年に米国で20歳未満の小児5,230人が脳腫瘍および脊髄腫瘍と診断されたと推定されています。このように、さまざまな神経疾患の有病率の上昇は、これらの疾患の治療と管理の必要性を生み出し、その結果、米国における神経内視鏡市場のプラス成長をもたらし、結果として北米の神経内視鏡市場を推進します。

当レポートでは、世界の神経内視鏡市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 神経内視鏡市場レポートのイントロダクション

第2章 神経内視鏡市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 神経内視鏡市場の主な要因の分析

  • 神経内視鏡市場の促進要因
  • 神経内視鏡市場の抑制要因と課題
  • 神経内視鏡市場の機会

第5章 神経内視鏡市場のポーターのファイブフォース分析

第6章 神経内視鏡市場のレイアウト

  • 製品別
    • 硬性神経内視鏡
    • 軟性神経内視鏡
  • 用途別
    • 経鼻
    • 脳室内
    • 経頭蓋
  • 使用性別
    • 再使用可能
    • 使い捨て
  • エンドユーザー別
    • 病院
    • 外来手術センター
    • その他
  • 地域
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 神経内視鏡市場の企業と製品のプロファイル

  • Adeor Medical AG
  • Machida Endoscope Co. Ltd
  • B. Braun SE
  • Schindler Endoskopie Technologie GmbH
  • Clarus Medical LLC
  • KARL STORZ
  • Locamed Ltd.
  • Ackermann Instrumente GmbH
  • Tonglu Wanhe Medical Instruments Co., Ltd.
  • Renishaw plc.
  • Cliniva Healthcare
  • Advin Healthcare
  • Aesculap Inc.
  • ClearMind Biomedical

第8章 KOLの見解

第9章 プロジェクトアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Neuroendoscopy Market in Global (2021-2030)
  • Table 3: Neuroendoscopy Market in Global by Product (2021-2030)
  • Table 4: Neuroendoscopy Market in Global by Application (2021-2030)
  • Table 5: Neuroendoscopy Market in Global by Usability (2021-2030)
  • Table 6: Neuroendoscopy Market in Global by End-User (2021-2030)
  • Table 7: Neuroendoscopy Market in Global by Geography (2021-2030)
  • Table 8: Neuroendoscopy Market in North America (2021-2030)
  • Table 9: Neuroendoscopy Market in North America by Country (2021-2030)
  • Table 10: Neuroendoscopy Market in the United States (2021-2030)
  • Table 11: Neuroendoscopy Market in Canada (2021-2030)
  • Table 12: Neuroendoscopy Market in Mexico (2021-2030)
  • Table 13: Neuroendoscopy Market in Europe (2021-2030)
  • Table 14: Neuroendoscopy Market in Europe by Country (2021-2030)
  • Table 15: Neuroendoscopy Market in France (2021-2030)
  • Table 16: Neuroendoscopy Market in Germany (2021-2030)
  • Table 17: Neuroendoscopy Market in the United Kingdom (2021-2030)
  • Table 18: Neuroendoscopy Market in Italy (2021-2030)
  • Table 19: Neuroendoscopy Market in Spain (2021-2030)
  • Table 20: Neuroendoscopy Market in the Rest of Europe (2021-2030)
  • Table 21: Neuroendoscopy Market in Asia-Pacific (2021-2030)
  • Table 22: Neuroendoscopy Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Neuroendoscopy Market in China (2021-2030)
  • Table 24: Neuroendoscopy Market in Japan (2021-2030)
  • Table 25: Neuroendoscopy Market in India (2021-2030)
  • Table 26: Neuroendoscopy Market in Australia (2021-2030)
  • Table 27: Neuroendoscopy Market in South Korea (2021-2030)
  • Table 28: Neuroendoscopy Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Neuroendoscopy Market in the Rest of the World (2021-2030)
  • Table 30: Neuroendoscopy Market in RoW by Region (2021-2030)
  • Table 31: Neuroendoscopy Market in the Middle East (2021-2030)
  • Table 32: Neuroendoscopy Market in Africa (2021-2030)
  • Table 33: Neuroendoscopy Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Neuroendoscopy Market in Global (2021-2030)
  • Figure 3: Neuroendoscopy Market in Global by Product (2021-2030)
  • Figure 4: Neuroendoscopy Market in Global by Application (2021-2030)
  • Figure 5: Neuroendoscopy Market in Global by Usability (2021-2030)
  • Figure 6: Neuroendoscopy Market in Global by End-User (2021-2030)
  • Figure 7: Neuroendoscopy Market in Global by Geography (2021-2030)
  • Figure 8: Neuroendoscopy Market in North America (2021-2030)
  • Figure 9: Neuroendoscopy Market in North America by Country (2021-2030)
  • Figure 10: Neuroendoscopy Market in the United States (2021-2030)
  • Figure 11: Neuroendoscopy Market in Canada (2021-2030)
  • Figure 12: Neuroendoscopy Market in Mexico (2021-2030)
  • Figure 13: Neuroendoscopy Market in Europe (2021-2030)
  • Figure 14: Neuroendoscopy Market in Europe by Country (2021-2030)
  • Figure 15: Neuroendoscopy Market in France (2021-2030)
  • Figure 16: Neuroendoscopy Market in Germany (2021-2030)
  • Figure 17: Neuroendoscopy Market in the United Kingdom (2021-2030)
  • Figure 18: Neuroendoscopy Market in Italy (2021-2030)
  • Figure 19: Neuroendoscopy Market in Spain (2021-2030)
  • Figure 20: Neuroendoscopy Market in the Rest of Europe (2021-2030)
  • Figure 21: Neuroendoscopy Market in Asia-Pacific (2021-2030)
  • Figure 22: Neuroendoscopy Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Neuroendoscopy Market in China (2021-2030)
  • Figure 24: Neuroendoscopy Market in Japan (2021-2030)
  • Figure 25: Neuroendoscopy Market in India (2021-2030)
  • Figure 26: Neuroendoscopy Market in Australia (2021-2030)
  • Figure 27: Neuroendoscopy Market in South Korea (2021-2030)
  • Figure 28: Neuroendoscopy Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Neuroendoscopy Market in the Rest of the World (2021-2030)
  • Figure 30: Neuroendoscopy Market in RoW by Region (2021-2030)
  • Figure 31: Neuroendoscopy Market in the Middle East (2021-2030)
  • Figure 32: Neuroendoscopy Market in Africa (2021-2030)
  • Figure 33: Neuroendoscopy Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0700

Neuroendoscopy Market By Product (Rigid Neuroendoscopes And Flexible Neuroendoscopes), Application (Transnasal Neuroendoscopy, Intraventricular Neuroendoscopy, And Transcranial Neuroendoscopy), Usability (Reusable And Disposable) End-User (Hospitals, Ambulatory Surgical Centers, And Others) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of neurological disorders, growing demand for minimally invasive procedures and various advantages associated with neuroendoscopic procedures

The global Neuroendoscopy Market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 4.91% during the forecast period from 2024 to 2030. The demand for neuroendoscopy is primarily being boosted by the rising prevalence of neurological disorders such as brain tumors. Additionally, the growing demand for minimally invasive procedures and various advantages associated with neuroendoscopic procedures are some of the key factors that are contributing to the growth of the neuroendoscopy market during the forecast period from 2024-2030.

Neuroendoscopy Market Dynamics:

As per data published by the American Society of Clinical Oncology

(ASCO) 2023, it was estimated that around 308,102 people were diagnosed with a primary brain or spinal cord tumor in 2020, globally. Of these, brain tumors accounted for 85% to 90% of all primary central nervous system (CNS) tumors. Thus the rising prevalence of neurological disorders such as brain tumors, will create a need for the treatment and management of such neurological disorders, thus resulting in the positive growth of the Neuroendoscopy market.

Another driver for the Neuroendoscopy market is the rising need for minimally invasive procedures and various advantages associated with neuroendoscopy procedures. The minimally invasive nature of neuroendoscopy often results in less blood loss during procedures, reducing the need for blood transfusions and lowering the overall surgical risk. Additionally, neuroendoscopy allows high-resolution imaging enabling surgeons to navigate and treat targeted areas with great accuracy. Further, the smaller incisions in the procedures reduce the risk of infection, as there is less exposure of internal tissue to external contaminants during the procedure. Thus, the various advantages associated with neuroendoscopy procedures and the growing demand for minimally invasive procedures are some of the key factors that will eventually boost the growth of the Neuroendoscopy market during the forecast period.

However, the high cost associated with neuroendoscopy procedures and devices and the shortage of skilled neurologists and endoscopists, are some of the key constraints that may limit the growth of the Neuroendoscopy market.

Neuroendoscopy Market Segment Analysis:

Neuroendoscopy Market by Product (Rigid Neuroendoscopes and Flexible Neuroendoscopes), Application (Transnasal Neuroendoscopy, Intraventricular Neuroendoscopy, and Transcranial Neuroendoscopy), Usability (Reusable and Disposable) End-User (Hospitals, Ambulatory Surgical Centers, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the Neuroendoscopy market, the Flexible Neuroendoscopy category is estimated to amass a significant revenue share in the Neuroendoscopy Market in 2023. This can be attributed to the various advantages provided by Flexible Neuroendoscopy. Flexible Neuroendoscopes are specialized medical instruments that possess flexible design providing the ability to navigate through the curved and intricate pathways within the brain providing enhanced access to complex structures. Additionally, the amount of flexibility provided by the flexible neuroendoscopes enables minimally invasive surgical procedures, reducing the need for large incisions, thus resulting in less tissue damage, reduced pain, and quicker recovery time. Further, the flexibility and maneuverability of these endoscopes allow surgeons to reach complex areas in the brain, ventricles, or spinal cord, which might be challenging to access with rigid instruments.

Therefore, owing to the above-mentioned factors, the Flexible Neuroendoscopy category is expected to register significant growth, thereby driving the growth of the overall Neuroendoscopy market during the forecast period.

North America is expected to dominate the overall Neuroendoscopy Market:

North America is expected to account for the highest proportion of the Neuroendoscopy Market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from various neurological disorders such as brain tumors. Additionally, the presence of developed and sophisticated healthcare infrastructure, rising technological advancements, and a highly potent market in terms of product development, and launches are some of the factors driving the growth of the Neuroendoscopy Market in North America.

According to the data provided by the American Society of Cancer 2023, it was estimated that around 24,810 cases (14,280 in males and 10,530 in females) of brain and spinal cord tumors were diagnosed in the United States, in the year 2023. Additionally, as per the data provided by the American Society of Clinical Oncology (ASCO) 2023, it was estimated that 5,230 children under the age of 20, were diagnosed with brain and spinal cord tumors in the United States, in the year 2023. Thus, the rising prevalence of various neurological disorders will create a need for the treatment and management of these disorders, thus resulting in the positive growth of the Neuroendoscopy Market in the United States, which will eventually propel the Neuroendoscopy market in North America.

Further, various key product launches and product approvals in the region are some of the other factors that are influencing the positive growth of the market in North America. For example, in January 2021, the US FDA granted 510k clearance to ClearMind Biomedical's new neuroendoscope, the Axonpen System.

Therefore, the factors mentioned above, and with the increasing product launches and product approvals in the region, are the factors responsible for driving the overall market for Neuroendoscopy in North America during the forecast period.

Neuroendoscopy Market Key Players:

Some of the key market players operating in the Neuroendoscopy market include Adeor Medical AG, Machida Endoscope Co. Ltd, B. Braun SE, Schindler Endoskopie Technologie GmbH, Clarus Medical LLC, KARL STORZ, Locamed Ltd., Ackermann Instrumente GmbH, Tonglu Wanhe Medical Instruments Co., Ltd., Renishaw plc, Cliniva Healthcare, Advin Healthcare, Aesculap Inc., ClearMind Biomedical, and others.

Recent Developmental Activities in the Neuroendoscopy Market:

  • In August 2021, ClearPoint Neuro Inc. entered into a strategic and commercial partnership with German-based surgical equipment leader Adeor Medical AG.
  • In January 2021, the US FDA granted 510k clearance to ClearMind Biomedical's new neuroendoscope, the Axonpen System.

Key Takeaways from the Neuroendoscopy Market Report Study

  • Market size analysis for current Neuroendoscopy Market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Neuroendoscopy market.
  • Various opportunities available for the other competitors in the Neuroendoscopy Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Neuroendoscopy market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Neuroendoscopy market growth in the coming future?

Target Audience who can be benefited from this Neuroendoscopy Market Report Study

  • Neuroendoscopy product providers
  • Research organizations and consulting companies
  • Neuroendoscopy market-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Neuroendoscopy
  • Various end-users who want to know more about the Neuroendoscopy Market and the latest technological developments in the Neuroendoscopy Market.

Frequently Asked Questions for the Neuroendoscopy Market:

1. What is meant by Neuroendoscopy?

Neuroendoscopy is a medical procedure, which is performed using an endoscope. An endoscope is a thin, flexible tube with a light and a camera placed at its tip, is used to visualize and perform surgical interventions within the brain, and spinal cord.

2. What is the market for Neuroendoscopy?

The global Neuroendoscopy Market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 4.91% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Neuroendoscopy market?

The Neuroendoscopy Market is slated to witness prosperity owing to factors such as the growing prevalence of neurological disorders such as brain tumors. Additionally, the growing demand for minimally invasive procedures and various advantages associated with neuroendoscopic procedures, are some of the other factors resulting in appreciable revenue growth in the Neuroendoscopy Market during the forecast period (2024-2030).

4. Who are the key players operating in the global Neuroendoscopy market?

Some of the key market players operating in the Neuroendoscopy Market include Adeor Medical AG, Machida Endoscope Co. Ltd, B. Braun SE, Schindler Endoskopie Technologie GmbH, Clarus Medical LLC, KARL STORZ, Locamed Ltd., Ackermann Instrumente GmbH, Tonglu Wanhe Medical Instruments Co., Ltd., Renishaw plc, Cliniva Healthcare, Advin Healthcare, Aesculap Inc., ClearMind Biomedical, and others.

5. Which region has the highest share in the global Neuroendoscopy market?

North America is expected to dominate the overall Neuroendoscopy Market during the forecast period, 2024 to 2030. This is due to the presence of a large patient pool suffering from various neurological disorders such as brain tumor. Additionally, the presence of developed and sophisticated healthcare infrastructure, rising technological advancements, and a highly potent market in terms of product development, and launches, are some of the key factors driving the growth of the Neuroendoscopy Market in North America.

Table of Contents

1. Neuroendoscopy Market Report Introduction

2. Neuroendoscopy Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Neuroendoscopy Market Key Factors Analysis

  • 4.1. Neuroendoscopy Market Drivers
    • 4.1.1. Rising prevalence of Neurological Disorders
    • 4.1.2. Growing demand for minimally invasive procedures and benefits associated with neuroendoscopy procedures
  • 4.2. Neuroendoscopy Market Restraints and Challenges
    • 4.2.1. High cost associated with the neuroendoscopy procedures and equipment
    • 4.2.2. Shortage of skilled neurologists and endoscopists
  • 4.3. Neuroendoscopy Market Opportunities
    • 4.3.1. Increasing technological advancement in the domain of neuroendoscopy

5. Neuroendoscopy Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Neuroendoscopy Market Layout

  • 6.1. By Product
    • 6.1.1. Rigid Neuroendoscopes
    • 6.1.2. Flexible Neuroendoscopes
  • 6.2. By Application
    • 6.2.1. Transnasal
    • 6.2.2. Intraventricular
    • 6.2.3. Transcranial
  • 6.3. By Usability
    • 6.3.1. Reusable
    • 6.3.2. Disposable
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centers
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America
      • 6.5.1.1. United States Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.1.2. Canada Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.1.3. Mexico Neuroendoscopy Market Size in USD million (2021-2030)
    • 6.5.2. Europe
      • 6.5.2.1. France Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.2.2. Germany Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.2.4. Italy Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.2.5. Spain Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Neuroendoscopy Market Size in USD million (2021-2030)
    • 6.5.3. Asia-Pacific
      • 6.5.3.1. China Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.3.2. Japan Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.3.3. India Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.3.4. Australia Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.3.5. South Korea Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Neuroendoscopy Market Size in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW)
      • 6.5.4.1. Middle East Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.4.2. Africa Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.4.3. South America Neuroendoscopy Market Size in USD million (2021-2030)

7. Neuroendoscopy Market Company and Product Profiles

  • 7.1. Adeor Medical AG
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Machida Endoscope Co. Ltd
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. B. Braun SE
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Schindler Endoskopie Technologie GmbH
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Clarus Medical LLC
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. KARL STORZ
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Locamed Ltd.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Ackermann Instrumente GmbH
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Tonglu Wanhe Medical Instruments Co., Ltd.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Renishaw plc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Cliniva Healthcare
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Advin Healthcare
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Aesculap Inc.
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. ClearMind Biomedical
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us